SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-016559
Filing Date
2020-07-02
Accepted
2020-07-02 16:03:05
Documents
2
Period of Report
2020-06-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1619
2 POWER OF ATTORNEY ea123771ex24_delmar.htm EX-24 5854
  Complete submission text file 0001213900-20-016559.txt   9030
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LA JOLLA PHARMACEUTICAL COMPANY LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address
Johnson Laura L. (Reporting) CIK: 0001589362 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37823 | Film No.: 201009205